Glaxosmithkline | Despesas De Vendas E Administração



Selling And Administration Expenses Alterar Data
AbbVie USD 3.25B 40M 2025-06
Amgen USD 1.69B 191M 2025-03
AstraZeneca USD 5.01B 1.42B 2025-06
Aurora Cannabis CAD 38.18M 2.05M 2024-12
Bausch Health Companies USD 894M 27M 2025-06
Bristol-Myers Squibb USD 1.71B 129M 2025-06
Canopy Growth CAD 40.62M 308K 2024-12
Corcept Therapeutics USD 103.85M 13.19M 2025-06
Drreddys Laboratories INR 21.59B 436M 2024-12
Eli Lilly USD 2.36B 62.3M 2025-03
GlaxoSmithKline GBP 2.14B 80M 2025-06
Glaxosmithkline GBP 2.7B 632M 2024-12
J&J USD 5.89B 777M 2025-06
Merck USD 2.63B 104M 2025-06
Novartis USD 3.44B 384M 2025-06
Pacira USD 86.78M 7.16M 2025-03
Perrigo USD 281.2M 46.4M 2025-03
Pfizer USD 3.01B 1.27B 2025-03
Prestige Brands USD 64.05M 73K 2025-03
Roche Holding CHF 3.61B 381M 2024-12
Sanofi EUR 2.63B 408M 2025-06
Supernus Pharmaceuticals USD 79.41M 9.66M 2024-12
Takeda JPY 255.89B 39.98B 2025-06
Teva Pharmaceutical Industries USD 959M 40M 2025-06
Zoetis USD 563M 62M 2025-03


Glaxosmithkline Despesas De Vendas E Administração - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Aug 2025.